Travis Nemkov
Concepts (629)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 55 | 2026 | 708 | 8.330 |
Why?
| | Blood Preservation | 31 | 2026 | 310 | 4.700 |
Why?
| | Metabolomics | 34 | 2026 | 715 | 3.500 |
Why?
| | Hemolysis | 13 | 2025 | 213 | 2.740 |
Why?
| | Metabolome | 24 | 2026 | 374 | 2.730 |
Why?
| | Blood Donors | 11 | 2025 | 117 | 2.380 |
Why?
| | Glycolysis | 23 | 2025 | 335 | 2.340 |
Why?
| | Erythrocyte Transfusion | 14 | 2026 | 211 | 1.600 |
Why?
| | Drosophila melanogaster | 11 | 2025 | 236 | 1.530 |
Why?
| | Drosophila Proteins | 10 | 2025 | 208 | 1.400 |
Why?
| | Mass Spectrometry | 11 | 2019 | 740 | 1.290 |
Why?
| | High-Throughput Screening Assays | 4 | 2021 | 161 | 1.240 |
Why?
| | Carnitine | 4 | 2024 | 87 | 1.070 |
Why?
| | Hypoxia | 11 | 2024 | 1177 | 1.020 |
Why?
| | Energy Metabolism | 11 | 2024 | 939 | 0.960 |
Why?
| | Oxidative Stress | 15 | 2025 | 1370 | 0.930 |
Why?
| | Amino Acids | 10 | 2023 | 511 | 0.920 |
Why?
| | Animals | 78 | 2026 | 38010 | 0.880 |
Why?
| | Membrane Lipids | 2 | 2021 | 82 | 0.810 |
Why?
| | Hemoglobins | 6 | 2025 | 365 | 0.800 |
Why?
| | Mice | 45 | 2026 | 18378 | 0.800 |
Why?
| | Proteomics | 8 | 2025 | 1161 | 0.770 |
Why?
| | Shock, Hemorrhagic | 7 | 2020 | 200 | 0.760 |
Why?
| | Erythroblasts | 1 | 2022 | 19 | 0.740 |
Why?
| | Blood Platelets | 5 | 2025 | 390 | 0.730 |
Why?
| | Athletic Performance | 1 | 2023 | 85 | 0.720 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 4 | 2025 | 32 | 0.710 |
Why?
| | Lipid Metabolism | 6 | 2021 | 524 | 0.680 |
Why?
| | Purines | 4 | 2022 | 185 | 0.680 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 65 | 0.650 |
Why?
| | Receptor, Adenosine A2B | 4 | 2025 | 65 | 0.640 |
Why?
| | Hematopoietic Stem Cells | 4 | 2026 | 417 | 0.620 |
Why?
| | Physical Exertion | 1 | 2021 | 209 | 0.620 |
Why?
| | Glucosephosphate Dehydrogenase | 4 | 2025 | 65 | 0.610 |
Why?
| | Humans | 107 | 2026 | 143560 | 0.610 |
Why?
| | Leukemia | 2 | 2019 | 245 | 0.610 |
Why?
| | Prescription Drugs | 1 | 2021 | 114 | 0.600 |
Why?
| | Fatty Acids | 7 | 2024 | 452 | 0.590 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2025 | 296 | 0.590 |
Why?
| | Carbon | 2 | 2017 | 205 | 0.570 |
Why?
| | Lymph | 2 | 2016 | 31 | 0.570 |
Why?
| | Iron | 3 | 2025 | 345 | 0.570 |
Why?
| | Cell Death | 1 | 2020 | 394 | 0.560 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.540 |
Why?
| | Leukemia, Myeloid, Acute | 7 | 2020 | 661 | 0.540 |
Why?
| | Anemia | 3 | 2024 | 177 | 0.520 |
Why?
| | Muscle, Skeletal | 9 | 2025 | 1787 | 0.520 |
Why?
| | Bone Marrow | 1 | 2018 | 301 | 0.510 |
Why?
| | Oxidation-Reduction | 11 | 2025 | 1091 | 0.500 |
Why?
| | Aging | 8 | 2024 | 1946 | 0.490 |
Why?
| | Altitude Sickness | 5 | 2018 | 150 | 0.490 |
Why?
| | Nitrogen | 1 | 2017 | 168 | 0.480 |
Why?
| | Transfusion Medicine | 1 | 2015 | 14 | 0.470 |
Why?
| | Exercise Tolerance | 3 | 2025 | 285 | 0.470 |
Why?
| | Mice, Inbred C57BL | 19 | 2026 | 6043 | 0.470 |
Why?
| | Biomarkers | 10 | 2024 | 4241 | 0.460 |
Why?
| | Kynurenine | 5 | 2024 | 115 | 0.450 |
Why?
| | Inflammation | 7 | 2024 | 2881 | 0.440 |
Why?
| | Male | 54 | 2025 | 71500 | 0.430 |
Why?
| | Exercise | 3 | 2023 | 2151 | 0.430 |
Why?
| | Proteome | 5 | 2025 | 494 | 0.420 |
Why?
| | Mitochondria | 8 | 2025 | 988 | 0.410 |
Why?
| | Lipids | 1 | 2019 | 704 | 0.410 |
Why?
| | Adenosine Triphosphate | 3 | 2025 | 488 | 0.400 |
Why?
| | Taste Buds | 1 | 2015 | 209 | 0.380 |
Why?
| | Female | 51 | 2026 | 77251 | 0.360 |
Why?
| | Healthy Volunteers | 7 | 2021 | 213 | 0.360 |
Why?
| | Neoplastic Stem Cells | 4 | 2021 | 414 | 0.360 |
Why?
| | Extracellular Vesicles | 2 | 2025 | 162 | 0.350 |
Why?
| | Hemorrhage | 2 | 2022 | 804 | 0.350 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2019 | 590 | 0.340 |
Why?
| | Oxygen | 5 | 2020 | 998 | 0.330 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 571 | 0.310 |
Why?
| | Adult | 29 | 2025 | 40013 | 0.310 |
Why?
| | Flavones | 2 | 2019 | 13 | 0.310 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2021 | 875 | 0.310 |
Why?
| | Glutathione | 4 | 2025 | 373 | 0.310 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2020 | 266 | 0.300 |
Why?
| | Sphingosine | 3 | 2023 | 47 | 0.300 |
Why?
| | Myelodysplastic Syndromes | 2 | 2023 | 143 | 0.300 |
Why?
| | Altitude | 4 | 2023 | 481 | 0.300 |
Why?
| | Blood Banks | 3 | 2019 | 47 | 0.300 |
Why?
| | Lysophospholipids | 3 | 2023 | 75 | 0.300 |
Why?
| | Rats, Sprague-Dawley | 8 | 2020 | 2531 | 0.300 |
Why?
| | Adenine | 2 | 2025 | 337 | 0.280 |
Why?
| | Alcohol Oxidoreductases | 2 | 2025 | 63 | 0.280 |
Why?
| | Neoplasm Proteins | 2 | 2025 | 443 | 0.280 |
Why?
| | Polyamines | 3 | 2024 | 44 | 0.270 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2025 | 1226 | 0.270 |
Why?
| | Acclimatization | 3 | 2018 | 172 | 0.260 |
Why?
| | Cold Temperature | 3 | 2025 | 201 | 0.260 |
Why?
| | Blood Transfusion | 4 | 2024 | 401 | 0.260 |
Why?
| | Thrombosis | 2 | 2022 | 401 | 0.260 |
Why?
| | Arginine | 3 | 2024 | 261 | 0.250 |
Why?
| | Hematopoiesis | 2 | 2018 | 194 | 0.250 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 464 | 0.250 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2017 | 48 | 0.250 |
Why?
| | Larva | 6 | 2025 | 239 | 0.250 |
Why?
| | Mammals | 3 | 2023 | 291 | 0.250 |
Why?
| | Sciuridae | 2 | 2019 | 147 | 0.250 |
Why?
| | Erythrocyte Aging | 2 | 2024 | 12 | 0.250 |
Why?
| | Gene Expression Regulation, Leukemic | 2 | 2016 | 57 | 0.250 |
Why?
| | Plasma | 3 | 2017 | 222 | 0.250 |
Why?
| | Chemokine CXCL13 | 1 | 2026 | 15 | 0.240 |
Why?
| | Oxygen Consumption | 4 | 2024 | 718 | 0.240 |
Why?
| | Cysteine | 2 | 2025 | 212 | 0.240 |
Why?
| | Signal Transduction | 9 | 2025 | 5214 | 0.240 |
Why?
| | Isotope Labeling | 2 | 2017 | 81 | 0.240 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2026 | 37 | 0.240 |
Why?
| | Cell Line, Tumor | 11 | 2026 | 3611 | 0.240 |
Why?
| | Wolbachia | 1 | 2025 | 3 | 0.240 |
Why?
| | Tryptophan | 4 | 2021 | 181 | 0.240 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2026 | 39 | 0.240 |
Why?
| | Mice, Knockout | 6 | 2025 | 3109 | 0.240 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 482 | 0.240 |
Why?
| | Drosophila | 2 | 2024 | 157 | 0.240 |
Why?
| | Macrophages, Peritoneal | 1 | 2026 | 89 | 0.240 |
Why?
| | Insulin Resistance | 3 | 2021 | 1234 | 0.230 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 182 | 0.230 |
Why?
| | Collagen | 2 | 2020 | 457 | 0.230 |
Why?
| | Erythropoiesis | 2 | 2023 | 56 | 0.230 |
Why?
| | Wounds and Injuries | 3 | 2020 | 941 | 0.230 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 2025 | 5 | 0.230 |
Why?
| | Qa-SNARE Proteins | 1 | 2025 | 20 | 0.230 |
Why?
| | Rats | 7 | 2021 | 5610 | 0.230 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 378 | 0.230 |
Why?
| | Coronavirus Infections | 2 | 2020 | 373 | 0.230 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2025 | 114 | 0.230 |
Why?
| | Interleukin-1 | 2 | 2021 | 970 | 0.230 |
Why?
| | Caffeine | 1 | 2025 | 72 | 0.220 |
Why?
| | Pentose Phosphate Pathway | 4 | 2018 | 53 | 0.220 |
Why?
| | Polymorphism, Genetic | 2 | 2025 | 626 | 0.220 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.220 |
Why?
| | Symbiosis | 1 | 2025 | 82 | 0.220 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 523 | 0.220 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 96 | 0.220 |
Why?
| | Phosphofructokinases | 1 | 2024 | 7 | 0.220 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2024 | 7 | 0.220 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2026 | 142 | 0.220 |
Why?
| | Hexokinase | 1 | 2024 | 17 | 0.220 |
Why?
| | Rejuvenation | 1 | 2024 | 19 | 0.220 |
Why?
| | Physical Conditioning, Animal | 2 | 2025 | 247 | 0.210 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2018 | 205 | 0.210 |
Why?
| | Stress, Physiological | 2 | 2025 | 453 | 0.210 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 69 | 0.210 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 17 | 0.210 |
Why?
| | Blood Group Antigens | 1 | 2023 | 16 | 0.210 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 14 | 0.210 |
Why?
| | Mitochondria, Muscle | 3 | 2021 | 121 | 0.210 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1064 | 0.210 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 28 | 0.210 |
Why?
| | DNA, Mitochondrial | 1 | 2025 | 211 | 0.210 |
Why?
| | Erythrocyte Deformability | 2 | 2021 | 19 | 0.210 |
Why?
| | Middle Aged | 15 | 2025 | 35342 | 0.200 |
Why?
| | Uric Acid | 1 | 2025 | 163 | 0.200 |
Why?
| | Emtricitabine | 1 | 2025 | 205 | 0.200 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 219 | 0.200 |
Why?
| | Chromatography, Liquid | 3 | 2025 | 453 | 0.200 |
Why?
| | Glutamine | 3 | 2019 | 109 | 0.200 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2023 | 29 | 0.200 |
Why?
| | Isoenzymes | 1 | 2024 | 299 | 0.200 |
Why?
| | Cerebral Hemorrhage | 1 | 2024 | 118 | 0.200 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 47 | 0.200 |
Why?
| | Succinates | 1 | 2023 | 24 | 0.200 |
Why?
| | Lactates | 1 | 2023 | 85 | 0.200 |
Why?
| | Oxidative Phosphorylation | 3 | 2018 | 209 | 0.190 |
Why?
| | Furin | 1 | 2022 | 14 | 0.190 |
Why?
| | Tenofovir | 1 | 2025 | 292 | 0.190 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 174 | 0.190 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 213 | 0.190 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 81 | 0.190 |
Why?
| | 2,3-Diphosphoglycerate | 5 | 2023 | 34 | 0.190 |
Why?
| | Down-Regulation | 1 | 2025 | 644 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 262 | 0.190 |
Why?
| | Protein Processing, Post-Translational | 3 | 2025 | 474 | 0.190 |
Why?
| | Autophagy | 1 | 2025 | 287 | 0.190 |
Why?
| | Equidae | 1 | 2022 | 7 | 0.190 |
Why?
| | src-Family Kinases | 1 | 2023 | 96 | 0.190 |
Why?
| | Histiocytosis | 1 | 2022 | 9 | 0.190 |
Why?
| | Obesity | 5 | 2021 | 3041 | 0.190 |
Why?
| | Alleles | 1 | 2025 | 893 | 0.180 |
Why?
| | Bicycling | 1 | 2023 | 122 | 0.180 |
Why?
| | Glucose | 3 | 2017 | 1042 | 0.180 |
Why?
| | Liver | 3 | 2019 | 1864 | 0.180 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 106 | 0.180 |
Why?
| | Erdheim-Chester Disease | 1 | 2021 | 4 | 0.180 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2022 | 195 | 0.180 |
Why?
| | Neutrophils | 2 | 2025 | 1134 | 0.180 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 236 | 0.170 |
Why?
| | Sulfonamides | 3 | 2020 | 582 | 0.170 |
Why?
| | Asparagine | 2 | 2018 | 32 | 0.170 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.170 |
Why?
| | Cholesterol | 2 | 2022 | 404 | 0.170 |
Why?
| | Sphingolipids | 2 | 2021 | 82 | 0.170 |
Why?
| | Erythrocyte Count | 1 | 2021 | 21 | 0.170 |
Why?
| | Auditory Pathways | 1 | 2021 | 53 | 0.170 |
Why?
| | Lactic Acid | 5 | 2024 | 308 | 0.170 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 190 | 0.170 |
Why?
| | Transgender Persons | 1 | 2024 | 205 | 0.170 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 66 | 0.170 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 31 | 0.170 |
Why?
| | Protein Domains | 1 | 2022 | 308 | 0.170 |
Why?
| | Metformin | 1 | 2024 | 331 | 0.170 |
Why?
| | Syndecan-1 | 1 | 2020 | 41 | 0.170 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 258 | 0.170 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 186 | 0.170 |
Why?
| | Virulence Factors | 1 | 2022 | 172 | 0.170 |
Why?
| | Testosterone | 1 | 2024 | 423 | 0.170 |
Why?
| | Resistance Training | 1 | 2023 | 170 | 0.170 |
Why?
| | Benzothiazoles | 2 | 2017 | 41 | 0.160 |
Why?
| | Cell Plasticity | 1 | 2021 | 39 | 0.160 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1452 | 0.160 |
Why?
| | Aged | 8 | 2024 | 25322 | 0.160 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 92 | 0.160 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 107 | 0.160 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 125 | 0.160 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 103 | 0.160 |
Why?
| | Stromal Cells | 1 | 2020 | 128 | 0.160 |
Why?
| | Osmotic Pressure | 1 | 2020 | 34 | 0.160 |
Why?
| | Tandem Mass Spectrometry | 3 | 2025 | 566 | 0.160 |
Why?
| | Cannabidiol | 1 | 2022 | 131 | 0.160 |
Why?
| | Phosphatidylserines | 1 | 2020 | 57 | 0.160 |
Why?
| | Phenylurea Compounds | 2 | 2017 | 100 | 0.160 |
Why?
| | TCF Transcription Factors | 1 | 2019 | 19 | 0.160 |
Why?
| | Taurine | 1 | 2020 | 40 | 0.160 |
Why?
| | Macrophage Activation | 1 | 2021 | 192 | 0.160 |
Why?
| | Cannabinoids | 1 | 2022 | 181 | 0.160 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2019 | 26 | 0.160 |
Why?
| | Time Factors | 10 | 2024 | 7031 | 0.160 |
Why?
| | Macrophages | 4 | 2022 | 1506 | 0.150 |
Why?
| | Hibernation | 2 | 2019 | 75 | 0.150 |
Why?
| | Ovarian Neoplasms | 1 | 2026 | 586 | 0.150 |
Why?
| | Transcription Factors | 2 | 2025 | 1754 | 0.150 |
Why?
| | Parabiosis | 1 | 2019 | 11 | 0.150 |
Why?
| | Shock | 1 | 2020 | 105 | 0.150 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 211 | 0.150 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2021 | 230 | 0.150 |
Why?
| | Tryptophan Oxygenase | 2 | 2018 | 34 | 0.150 |
Why?
| | Hydrogen Peroxide | 1 | 2021 | 339 | 0.150 |
Why?
| | Torpor | 1 | 2019 | 14 | 0.150 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 337 | 0.150 |
Why?
| | Circadian Clocks | 1 | 2019 | 58 | 0.150 |
Why?
| | Quantitative Trait Loci | 3 | 2025 | 368 | 0.150 |
Why?
| | Anemia, Sickle Cell | 2 | 2024 | 280 | 0.140 |
Why?
| | Cell Proliferation | 6 | 2026 | 2542 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 928 | 0.140 |
Why?
| | Cigarette Smoking | 1 | 2020 | 101 | 0.140 |
Why?
| | Homeostasis | 2 | 2022 | 641 | 0.140 |
Why?
| | Aspartic Acid | 1 | 2018 | 82 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2024 | 556 | 0.140 |
Why?
| | Gene-Environment Interaction | 1 | 2020 | 191 | 0.140 |
Why?
| | Blood Specimen Collection | 1 | 2018 | 38 | 0.140 |
Why?
| | Machine Learning | 2 | 2021 | 574 | 0.140 |
Why?
| | Adenosine | 2 | 2017 | 251 | 0.140 |
Why?
| | Hypertension, Pulmonary | 2 | 2021 | 1957 | 0.140 |
Why?
| | Arousal | 1 | 2019 | 158 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 164 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2020 | 171 | 0.140 |
Why?
| | Stem Cell Niche | 1 | 2018 | 59 | 0.140 |
Why?
| | Deamination | 1 | 2017 | 6 | 0.140 |
Why?
| | Proteostasis | 1 | 2018 | 27 | 0.140 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 12 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2020 | 246 | 0.140 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 373 | 0.140 |
Why?
| | Hemoglobin A | 1 | 2017 | 20 | 0.140 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 19 | 0.140 |
Why?
| | Benzeneacetamides | 1 | 2017 | 8 | 0.140 |
Why?
| | Diglycerides | 1 | 2018 | 60 | 0.140 |
Why?
| | Cryopreservation | 1 | 2018 | 107 | 0.140 |
Why?
| | Glutaminase | 1 | 2017 | 11 | 0.140 |
Why?
| | Anti-HIV Agents | 1 | 2025 | 861 | 0.130 |
Why?
| | Transcriptome | 2 | 2021 | 1029 | 0.130 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4522 | 0.130 |
Why?
| | Calcium | 2 | 2022 | 1183 | 0.130 |
Why?
| | Thiadiazoles | 1 | 2017 | 27 | 0.130 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 49 | 0.130 |
Why?
| | Nicotine | 1 | 2020 | 342 | 0.130 |
Why?
| | Immune System | 1 | 2018 | 183 | 0.130 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 20 | 0.130 |
Why?
| | Resuscitation | 2 | 2018 | 301 | 0.130 |
Why?
| | Limit of Detection | 1 | 2017 | 95 | 0.130 |
Why?
| | Basigin | 1 | 2017 | 24 | 0.130 |
Why?
| | Body Fluids | 1 | 2017 | 70 | 0.130 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 732 | 0.130 |
Why?
| | Nitriles | 1 | 2018 | 193 | 0.130 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 7 | 0.130 |
Why?
| | Mutation | 6 | 2025 | 4053 | 0.130 |
Why?
| | Citric Acid | 1 | 2016 | 33 | 0.130 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 165 | 0.120 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 73 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2177 | 0.120 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 41 | 0.120 |
Why?
| | Young Adult | 8 | 2021 | 13972 | 0.120 |
Why?
| | Inflammasomes | 1 | 2018 | 146 | 0.120 |
Why?
| | Breast Neoplasms | 2 | 2020 | 2318 | 0.120 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 341 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2025 | 894 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2020 | 781 | 0.120 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 127 | 0.120 |
Why?
| | Brain Death | 1 | 2016 | 51 | 0.120 |
Why?
| | Neoplasms | 2 | 2022 | 2804 | 0.120 |
Why?
| | Folic Acid | 1 | 2017 | 199 | 0.120 |
Why?
| | Reperfusion Injury | 1 | 2018 | 292 | 0.120 |
Why?
| | Diethylhexyl Phthalate | 1 | 2015 | 15 | 0.120 |
Why?
| | Phosphatidylethanolamines | 1 | 2016 | 76 | 0.120 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2016 | 98 | 0.120 |
Why?
| | Metabolic Flux Analysis | 1 | 2015 | 7 | 0.120 |
Why?
| | Reactive Oxygen Species | 4 | 2022 | 642 | 0.120 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 156 | 0.120 |
Why?
| | Biochemistry | 1 | 2015 | 36 | 0.120 |
Why?
| | Models, Biological | 2 | 2021 | 1831 | 0.120 |
Why?
| | Antioxidants | 1 | 2019 | 594 | 0.120 |
Why?
| | Anoikis | 1 | 2015 | 31 | 0.120 |
Why?
| | Bacteria | 1 | 2022 | 888 | 0.120 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 441 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 266 | 0.110 |
Why?
| | Acidosis | 1 | 2016 | 105 | 0.110 |
Why?
| | Fluid Therapy | 1 | 2016 | 143 | 0.110 |
Why?
| | Phosphatidylcholines | 1 | 2016 | 131 | 0.110 |
Why?
| | Glutarates | 2 | 2025 | 11 | 0.110 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2015 | 57 | 0.110 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 92 | 0.110 |
Why?
| | Vasodilation | 1 | 2018 | 515 | 0.110 |
Why?
| | Blood Volume | 1 | 2015 | 65 | 0.110 |
Why?
| | Pandemics | 2 | 2020 | 1668 | 0.110 |
Why?
| | Citrates | 1 | 2014 | 41 | 0.110 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 432 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 637 | 0.110 |
Why?
| | Amyloid beta-Peptides | 1 | 2017 | 235 | 0.110 |
Why?
| | Platelet Transfusion | 1 | 2015 | 79 | 0.110 |
Why?
| | Extinction, Biological | 1 | 2015 | 39 | 0.110 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 154 | 0.110 |
Why?
| | Organ Preservation Solutions | 1 | 2014 | 47 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2021 | 861 | 0.110 |
Why?
| | Sulfur | 3 | 2022 | 63 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2025 | 2194 | 0.110 |
Why?
| | Cells, Cultured | 5 | 2021 | 4182 | 0.110 |
Why?
| | Linear Models | 1 | 2017 | 858 | 0.110 |
Why?
| | Reproducibility of Results | 2 | 2026 | 3380 | 0.110 |
Why?
| | Adipose Tissue | 2 | 2017 | 654 | 0.110 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2017 | 639 | 0.110 |
Why?
| | Health Status | 1 | 2019 | 824 | 0.110 |
Why?
| | Sodium Chloride | 1 | 2014 | 141 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 962 | 0.100 |
Why?
| | Phosphates | 1 | 2014 | 178 | 0.100 |
Why?
| | Methionine | 3 | 2020 | 158 | 0.100 |
Why?
| | Proteolysis | 3 | 2020 | 175 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 755 | 0.100 |
Why?
| | Peptide Fragments | 1 | 2017 | 698 | 0.100 |
Why?
| | Fetal Development | 1 | 2016 | 301 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 587 | 0.100 |
Why?
| | Glucose Tolerance Test | 3 | 2021 | 368 | 0.100 |
Why?
| | Antineoplastic Agents | 3 | 2019 | 2195 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 4152 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2575 | 0.100 |
Why?
| | Muscles | 2 | 2023 | 331 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 539 | 0.090 |
Why?
| | Nuclear Proteins | 1 | 2017 | 749 | 0.090 |
Why?
| | Diet | 1 | 2020 | 1290 | 0.090 |
Why?
| | MicroRNAs | 1 | 2018 | 698 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 833 | 0.090 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 2 | 2025 | 16 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 607 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 681 | 0.090 |
Why?
| | Microbiota | 1 | 2018 | 759 | 0.080 |
Why?
| | Mice, Inbred NOD | 3 | 2017 | 607 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2019 | 941 | 0.080 |
Why?
| | Liver Neoplasms | 1 | 2016 | 758 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2016 | 1125 | 0.080 |
Why?
| | HIV Infections | 1 | 2025 | 3013 | 0.080 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 58 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 3 | 2023 | 963 | 0.080 |
Why?
| | Cell Line | 3 | 2022 | 2897 | 0.080 |
Why?
| | Bisphosphoglycerate Mutase | 2 | 2021 | 7 | 0.080 |
Why?
| | Insulin | 2 | 2021 | 2497 | 0.070 |
Why?
| | Phenotype | 4 | 2020 | 3211 | 0.070 |
Why?
| | Cattle | 2 | 2022 | 990 | 0.070 |
Why?
| | Glucose Clamp Technique | 2 | 2021 | 198 | 0.070 |
Why?
| | Phosphorylation | 3 | 2018 | 1781 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 924 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2020 | 158 | 0.070 |
Why?
| | Diet, High-Fat | 2 | 2019 | 260 | 0.070 |
Why?
| | Macaca | 2 | 2018 | 65 | 0.070 |
Why?
| | Adolescent | 3 | 2024 | 22481 | 0.070 |
Why?
| | Brain | 2 | 2021 | 2892 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 280 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2021 | 790 | 0.070 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2018 | 202 | 0.070 |
Why?
| | Bacterial Proteins | 2 | 2025 | 944 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1827 | 0.060 |
Why?
| | Sex Characteristics | 2 | 2023 | 793 | 0.060 |
Why?
| | Apoptosis | 3 | 2021 | 2519 | 0.060 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 47 | 0.060 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 78 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1487 | 0.060 |
Why?
| | Cell Adhesion | 2 | 2018 | 456 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 686 | 0.060 |
Why?
| | Neurons | 1 | 2015 | 1636 | 0.060 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 431 | 0.060 |
Why?
| | Mice, Nude | 2 | 2018 | 710 | 0.060 |
Why?
| | Pupa | 1 | 2025 | 14 | 0.060 |
Why?
| | Biopsy | 2 | 2020 | 1083 | 0.060 |
Why?
| | Isotonic Solutions | 2 | 2016 | 39 | 0.060 |
Why?
| | Swine | 2 | 2018 | 837 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 45 | 0.060 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2025 | 15 | 0.060 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2025 | 69 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2025 | 61 | 0.060 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 40 | 0.060 |
Why?
| | Plateletpheresis | 1 | 2024 | 29 | 0.050 |
Why?
| | Deferoxamine | 1 | 2024 | 26 | 0.050 |
Why?
| | Antimalarials | 1 | 2024 | 34 | 0.050 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 162 | 0.050 |
Why?
| | Cell Survival | 2 | 2019 | 1136 | 0.050 |
Why?
| | RNA Interference | 2 | 2017 | 474 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2024 | 10 | 0.050 |
Why?
| | Alanine | 1 | 2025 | 171 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Cell Division | 1 | 2026 | 806 | 0.050 |
Why?
| | Cell Lineage | 1 | 2026 | 368 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 861 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 108 | 0.050 |
Why?
| | Organophosphates | 1 | 2025 | 184 | 0.050 |
Why?
| | Respiratory Therapy | 1 | 2023 | 25 | 0.050 |
Why?
| | Blood Glucose | 3 | 2020 | 2316 | 0.050 |
Why?
| | Endothelial Cells | 2 | 2020 | 846 | 0.050 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2024 | 95 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 637 | 0.050 |
Why?
| | Doxorubicin | 1 | 2026 | 381 | 0.050 |
Why?
| | Africa South of the Sahara | 1 | 2023 | 47 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 162 | 0.050 |
Why?
| | Pantothenic Acid | 1 | 2023 | 5 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2024 | 148 | 0.050 |
Why?
| | Acyl Coenzyme A | 1 | 2023 | 31 | 0.050 |
Why?
| | Puberty | 1 | 2024 | 158 | 0.050 |
Why?
| | Dasatinib | 1 | 2023 | 59 | 0.050 |
Why?
| | Prospective Studies | 3 | 2021 | 7899 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2023 | 140 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2023 | 58 | 0.050 |
Why?
| | Hand Strength | 1 | 2023 | 136 | 0.050 |
Why?
| | Heme | 1 | 2023 | 84 | 0.050 |
Why?
| | Pyrimidinones | 1 | 2023 | 127 | 0.050 |
Why?
| | Cell Cycle | 1 | 2026 | 648 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2025 | 589 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2024 | 227 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 80 | 0.050 |
Why?
| | Adipocytes | 1 | 2023 | 222 | 0.040 |
Why?
| | Thrombin | 1 | 2022 | 169 | 0.040 |
Why?
| | Pyridones | 1 | 2023 | 198 | 0.040 |
Why?
| | Cell Movement | 2 | 2017 | 973 | 0.040 |
Why?
| | Cytokines | 2 | 2022 | 2097 | 0.040 |
Why?
| | Horses | 1 | 2022 | 202 | 0.040 |
Why?
| | Subcellular Fractions | 1 | 2021 | 76 | 0.040 |
Why?
| | Dogs | 1 | 2022 | 427 | 0.040 |
Why?
| | Oncogenes | 1 | 2021 | 119 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 55 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2022 | 2852 | 0.040 |
Why?
| | Candidiasis | 1 | 2021 | 62 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 111 | 0.040 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2020 | 14 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 138 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2022 | 271 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 97 | 0.040 |
Why?
| | Cochlea | 1 | 2021 | 71 | 0.040 |
Why?
| | Point Mutation | 1 | 2021 | 243 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2023 | 337 | 0.040 |
Why?
| | Cystine | 1 | 2020 | 18 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5891 | 0.040 |
Why?
| | Muscle Strength | 1 | 2023 | 333 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 249 | 0.040 |
Why?
| | Fat Body | 1 | 2020 | 8 | 0.040 |
Why?
| | Genome | 1 | 2022 | 309 | 0.040 |
Why?
| | Creatine | 1 | 2020 | 63 | 0.040 |
Why?
| | Niacinamide | 1 | 2020 | 82 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 175 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 3 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 34 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 3080 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2019 | 20 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 46 | 0.040 |
Why?
| | Gene Deletion | 1 | 2021 | 394 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2019 | 194 | 0.040 |
Why?
| | Megakaryocytes | 1 | 2019 | 35 | 0.040 |
Why?
| | Phylogeny | 1 | 2023 | 1008 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 197 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2020 | 152 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 10 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 30 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 191 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 94 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 284 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 257 | 0.040 |
Why?
| | Succinic Acid | 1 | 2018 | 41 | 0.040 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2092 | 0.040 |
Why?
| | Drug Design | 1 | 2019 | 173 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 90 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 2017 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 1015 | 0.040 |
Why?
| | Creatinine | 1 | 2020 | 494 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 576 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 197 | 0.040 |
Why?
| | Purine Nucleotides | 1 | 2018 | 12 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2021 | 510 | 0.030 |
Why?
| | Gluconeogenesis | 1 | 2018 | 83 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 82 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 38 | 0.030 |
Why?
| | Methylation | 1 | 2018 | 243 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 369 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2024 | 688 | 0.030 |
Why?
| | Formic Acid Esters | 1 | 2017 | 3 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.030 |
Why?
| | Crush Injuries | 1 | 2017 | 12 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2621 | 0.030 |
Why?
| | Metabolism | 1 | 2017 | 43 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2017 | 90 | 0.030 |
Why?
| | Azacitidine | 1 | 2018 | 149 | 0.030 |
Why?
| | Biological Transport | 1 | 2018 | 412 | 0.030 |
Why?
| | Pyrroles | 1 | 2018 | 210 | 0.030 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2017 | 41 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 147 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 16 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5743 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1524 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 245 | 0.030 |
Why?
| | Fluorenes | 1 | 2017 | 45 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 225 | 0.030 |
Why?
| | Blood Proteins | 1 | 2019 | 247 | 0.030 |
Why?
| | Sulfones | 1 | 2018 | 127 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 23 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 370 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2830 | 0.030 |
Why?
| | Cystathionine | 1 | 2016 | 22 | 0.030 |
Why?
| | Anaerobiosis | 1 | 2017 | 65 | 0.030 |
Why?
| | Periodicity | 1 | 2016 | 56 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1505 | 0.030 |
Why?
| | Weaning | 1 | 2016 | 46 | 0.030 |
Why?
| | Femoral Fractures | 1 | 2017 | 81 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 107 | 0.030 |
Why?
| | Nucleotides | 1 | 2017 | 126 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 3006 | 0.030 |
Why?
| | Quality Control | 1 | 2017 | 160 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 1022 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 108 | 0.030 |
Why?
| | NADP | 1 | 2016 | 51 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 277 | 0.030 |
Why?
| | Hydrazines | 1 | 2016 | 36 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2018 | 236 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 29 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2016 | 50 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 82 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1507 | 0.030 |
Why?
| | Hydrogen Sulfide | 1 | 2016 | 48 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 37 | 0.030 |
Why?
| | Sesquiterpenes | 1 | 2016 | 53 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 242 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 78 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 128 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 517 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 215 | 0.030 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2016 | 80 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 104 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 143 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 309 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 619 | 0.030 |
Why?
| | Body Temperature | 1 | 2016 | 224 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 160 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1117 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 392 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 273 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1314 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 702 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 319 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2018 | 263 | 0.030 |
Why?
| | Bison | 1 | 2015 | 6 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 259 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 135 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 1044 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1622 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2015 | 134 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 213 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 248 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1510 | 0.030 |
Why?
| | Body Size | 1 | 2015 | 94 | 0.030 |
Why?
| | Sirolimus | 1 | 2016 | 278 | 0.030 |
Why?
| | Glycosylation | 1 | 2015 | 173 | 0.030 |
Why?
| | Europe | 1 | 2015 | 410 | 0.030 |
Why?
| | Indoles | 1 | 2018 | 479 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 372 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 526 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 949 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 356 | 0.030 |
Why?
| | Running | 1 | 2017 | 229 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 7153 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1192 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 301 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2018 | 365 | 0.030 |
Why?
| | Biomedical Research | 1 | 2020 | 699 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1171 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 556 | 0.030 |
Why?
| | Skull | 1 | 2015 | 152 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 1013 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 624 | 0.030 |
Why?
| | Postpartum Period | 1 | 2016 | 352 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 518 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1369 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 1058 | 0.030 |
Why?
| | Up-Regulation | 1 | 2016 | 863 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2936 | 0.020 |
Why?
| | Survival Analysis | 1 | 2016 | 1332 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2016 | 300 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1511 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 682 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 447 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2429 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3625 | 0.020 |
Why?
| | Athletes | 1 | 2016 | 419 | 0.020 |
Why?
| | Fetus | 1 | 2016 | 806 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 685 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 732 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2165 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2942 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 2261 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11365 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8072 | 0.020 |
Why?
| | United States | 1 | 2015 | 15553 | 0.010 |
Why?
|
|
Nemkov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|